Skip to main content
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
letter
. 2012 Jun 29;18(5):791. doi: 10.1007/s10156-012-0443-2

Reply to swine flu and hemophagocytic syndrome

Nobuhiro Asai 1,, Yoshihiro Ohkuni 1, Ryo Matsunuma 1, Kanichi Iwama 2, Yoshihito Otsuka 3, Yasutaka Kawamura 4, Shinji Motojima 5, Norihiro Kaneko 1
PMCID: PMC7102375  PMID: 22740188

To the Editor

Dr. Viroj indicated that other infection could not be ruled out in our case [1]. While the patient received erythromycin 1,000 mg/day IV for 5 days, no bacterial pathogens were detected in sputum cultures by bronchoalveolar lavage fluid (BALF). All viral antibody tests such as for parainfluenza, coxsackie, rhinovirus, and RS virus were negative; only that for flu A was positive. We believe that influenza virus (H1N1) pneumonia should be diagnosed with radiologic findings.

Dr. Viroj suggested that there is no proof that virus-associated hemophagocytic syndrome (VAHS) in the cases reported by Beutel [2] is totally caused by swine flu virus induction. Unfortunately, we could not confirm that Beutel et al. ruled out other causes of hemophagocytic syndrome (HPS) in the report. However, we guess that occurrence of HPS triggers a similar cytokine storm similarly in those patients, resulting in severe inflammation such as acute respiratory distress syndrome (ARDS) or systemic inflammatory response syndrome (SIRS) [3]. Thus, bicytopenia or pancytopenia should be monitored. Although previous reports have not demonstrated that influenza virus is a common pathogen causing HPS [4], we think that HPS could possibly occur in patients with influenza virus (H1N1).

Acknowledgments

We are grateful for the diligent and thorough critical reading of our manuscript by Mr. John Wocher, Executive Vice President and Director, International Affairs/International Patient Services, Kameda Medical Center (Japan).

Footnotes

This article refers to the Letter to the editor at doi:10.1007/s10156-012-0442-3.

References

  • 1.Asai N, Ohkuni Y, Matsunuma R, Iwama K, Otsuka Y, Kawamura Y, et al. A case of novel swine influenza A (H1N1) pneumonia complicated with virus-associated hemophagocytic syndrome. J Infect Chemother 2012 (Epub ahead of print). [DOI] [PMC free article] [PubMed]
  • 2.Beutel G, Wiesner O, Eder M, Hafer C, Schneider AS, Kielstein JT, et al. Virus-associated hemophagocytic syndrome as a major contributor to death in patients with 2009 influenza A (H1N1) infection. Crit Care. 2011;15:R80. doi: 10.1186/cc10073. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Writing Committee of the WHO Consultation on Clinical Aspects of Pandemic (H1N1) 2009 Influenza. Bautista E, Chotpitayasunondh T, Gao Z, Harper SA, Shaw M, Uyeki TM, et al. Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N Engl J Med. 2010;362:1708–1719. doi: 10.1056/NEJMra1000449. [DOI] [PubMed] [Google Scholar]
  • 4.Fisman DN. Hemophagocytic syndromes and infection. Emerg Infect Dis. 2000;6:601–608. doi: 10.3201/eid0606.000608. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Infection and Chemotherapy are provided here courtesy of Nature Publishing Group

RESOURCES